What's behind Reckitt Benckiser's latest 2.0% stock surge?

Traders Union
All News
Stocks
Reckitt benckiser rises 2.03% today

Highlights

Reckitt Benckiser reported Q3 2026 core revenue of £2.69 billion, with manufacturing issues affecting Lysol and weak vitamin demand in China.
Management adjusted guidance, began a £500 million share buyback with £90 million completed, and plans to close its Russia Hygiene business in 2026.
Shares of Reckitt Benckiser show strong momentum and are forecast to trade in a GBX5,361 to GBX5,703 range over five sessions, with a high probability of further gains.

Mixed Q3 results prompt outlook shift amid buybacks and divestments

Reckitt Benckiser reported Q3 2026 core revenue of £2.69 billion, citing mixed performance across regions as manufacturing challenges affected Lysol and China saw weak demand for vitamins. The company adjusted its outlook but indicated expectations for recovery in Lysol and North America, and noted strong over-the-counter cold medicine sales. Reckitt Benckiser initiated a £500 million share buyback on August 5, 2026, having repurchased £90 million by October 23, 2026, and further buybacks are planned. Additional corporate actions included launching a £10 billion Euro Medium Term Note programme and planning for divestments, such as the expected closure of its Russia Hygiene business in the second half of 2026.

Anton Kharitonov, expert at Traders Union, notes that Reckitt Benckiser’s recent rally is propped up by a sizable share buyback and bullish technical levels. He points out mixed revenue results, with continued manufacturing hurdles and weak China demand raising red flags for sustainable growth. The buyback can mask underlying business fragility, and the overbought risk is mounting as Bull/Bear Power stays elevated. Margins could be pressured if operational improvements lag, especially as divestments and new debt plans add complexity. "Unless core performance improves materially, I remain cautious on RKT and see downside risks outweighing near-term technical momentum."

Viktoras Karapetjanc, expert at Traders Union, sees Reckitt Benckiser in a strong tactical position after a positive earnings reaction and continued buyback activity. He emphasizes that the bullish structure remains intact as the company targets recovery in Lysol and North America, while also benefiting from over-the-counter cold medicine demand. Active share repurchases and proactive financial measures reinforce confidence in management’s vision. "The market offers multiple setups above GBX5,220, and further growth is likely with plenty of upside potential if momentum persists."

Jainam Mehta, market strategist, believes RKT’s technical structure supports a scenario of price consolidation near current levels. He notes that the intraday rally has stretched the bullish move, but momentum remains intact and overbought risks are not yet confirmed by RSI. "A potential breakout above GBX5,703 could open the way for tactical long trades, while a dip below GBX5,361 would warrant caution for active positions."

Uptrend confirmed as buying signals persist near resistance band

RKT trades above its 20-day (GBX5,316), 50-day (GBX5,157), and 200-day (GBX5,220) moving averages, reflecting positive momentum across all timeframes. The Ichimoku Kijun at GBX5,232 further highlights the ongoing uptrend, with the nearest resistance at GBX5,703 and support at GBX5,484. Momentum indicators remain constructive, as both MACD and ADX signal buying. The RSI stands at 56.57, below overbought levels, and Stochastic RSI stays bullish. While the CCI and Awesome Oscillator are neutral, Bull/Bear Power is elevated, revealing dominant buying and some overbought risk. Intraday, RKT is near its session high in a 1.74% range, with strong buying interest continuing to drive momentum.

Earlier, analysts noted that Reckitt Benckiser was exhibiting a balanced technical outlook, with both bullish and bearish factors keeping the stock in a sideways trend while highlighting the potential for a breakout. The latest technical and corporate developments reinforce this assessment, with traders advised to monitor the GBX5,703 level as a pivotal resistance point that could determine the trajectory of the next move.

Source of Data: RKT Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.